This inventor holds 1 USPTO granted patent. Top assignee: Genetic Systems Corporation. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Janela McClure: Inventor in Antibody Research
Introduction
Janela McClure is an inventor associated with Vashon Island, Washington, and Genetic Systems Corporation. Her patent work concerns human monoclonal antibodies designed to recognize lymphadenopathy-associated virus, also known as LAV/HTLV-III.
Latest Patents
McClure is credited with 1 patent: “Human monoclonal antibody to lymphadenopathy-associated virus.” The patent describes human monoclonal antibodies that specifically react with an antigenic determinant of LAV/HTLV-III, along with cell lines that produce those antibodies. The antibodies are proposed for detecting the virus in biological samples and separating its specific antigenic determinants from mixtures. The disclosure also covers pharmaceutical compositions containing the antibodies and their use to significantly reduce viral infectivity in animals.
Career Highlights
McClure’s documented patent contribution focuses on antibody-based approaches to viral detection, antigen separation, and reducing infectivity. The patent is associated with Genetic Systems Corporation.
Collaborations
The patent’s association with Genetic Systems Corporation reflects a connection between McClure’s invention and the company’s work on monoclonal antibodies and viral research.
Conclusion
Janela McClure’s patent documents an antibody-based invention with proposed applications in identifying LAV/HTLV-III, isolating its antigenic determinants, and reducing infectivity in animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile